Journal article

Participant recruitment into a community-based diabetes prevention trial in India: Learnings from the Kerala Diabetes Prevention Program

Thirunavukkarasu Sathish, Zahra Aziz, Pilvikki Absetz, Kavumpurathu Raman Thankappan, Robyn Jennifer Tapp, Sajitha Balachandran, Suman Surendra Shetty, Brian Oldenburg

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS | ELSEVIER INC | Published : 2019

Abstract

Background: Data on participant recruitment into diabetes prevention trials are limited in low- and middle-income countries (LMICs). We aimed to provide a detailed analysis of participant recruitment into a community-based diabetes prevention trial in India. Methods: The Kerala Diabetes Prevention Program was conducted in 60 polling areas (electoral divisions) of the Neyyatinkara taluk (subdistrict) in Trivandrum district, Kerala state. Individuals (age 30-60 years) were screened with the Indian Diabetes Risk Score (IDRS) at their homes followed by an oral glucose tolerance test (OGTT) at community-based clinics. Individuals at high-risk of developing diabetes (IDRS score ≥60 and without dia..

View full abstract

Grants

Awarded by National Health and Medical Research Council, Australia


Awarded by ASCEND Program - Fogarty International Centre of the National Institutes of Health (NIH)


Funding Acknowledgements

K-DPP was funded by the National Health and Medical Research Council, Australia (Project Grant ID 1005324). TS was supported by the Victoria India Doctoral Scholarship (VIDS) for his PhD at the University of Melbourne, Australia. TS was also supported by the ASCEND Program, funded by the Fogarty International Centre of the National Institutes of Health (NIH) under Award Number: D43TW008332. We also acknowledge Peers for Progress, a programme of the American Academy of Family Physicians Foundation supported by the Eli Lily and Company Foundation. The contents of this paper are solely the responsibility of the authors and do not reflect the views of NHMRC, NIH, Peers for Progress or the ASCEND Program.